Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals significant survival differences in HPV-positive versus negative oropharyngeal carcinoma, indicating urgent management needs.
Background Oropharyngeal squamous cell carcinoma (OPSCC) shows distinct clinical patterns based on HPV status. In the UK, rising HPV‐positive cases have changed the disease's demographics and prognosis. While nodal involvement is a key prognostic factor, a subset presents with radiologically node‐negative (N0) disease, where optimal management is unclear. This study examines survival outcomes in these patients, stratified by HPV status. Methods A retrospective analysis of 1001 OPSCC cases (2012–2020) identified 249 N0 patients. After excluding 39 with unknown HPV status, 210 cases (37% HPV‐positive) were analyzed. Demographic, clinical, and treatment data were assessed, with survival analyzed using Kaplan–Meier curves. Results Overall survival was 56.2%, significantly higher in HPV‐positive patients (75.3% vs. 45.1%, p < 0.001). HPV‐negative patients had a smaller tumor size, were more often female, with higher smoking, alcohol use, and deprivation. Despite earlier T‐stage, they had worse performance scores and received surgery or supportive care more often. Discussion HPV negative OPSCC retains poor prognosis even in node‐negative OPSCC and smaller tumor size on presentation.
No takes yet. Share an insight, caveat, or question.
Elmarghani et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: